198 related articles for article (PubMed ID: 1338083)
21. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
Sato A; Suzuki Y; Saruta T
Hypertens Res; 1999 Mar; 22(1):17-22. PubMed ID: 10221346
[TBL] [Abstract][Full Text] [Related]
22. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
[TBL] [Abstract][Full Text] [Related]
23. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.
Dahlöf B; Gosse P; Guéret P; Dubourg O; de Simone G; Schmieder R; Karpov Y; García-Puig J; Matos L; De Leeuw PW; Degaute JP; Magometschnigg D;
J Hypertens; 2005 Nov; 23(11):2063-70. PubMed ID: 16208150
[TBL] [Abstract][Full Text] [Related]
24. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
[TBL] [Abstract][Full Text] [Related]
25. Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension.
Spoelstra-de Man AM; van Ittersum FJ; Schram MT; Kamp O; van Dijk RA; Ijzerman RG; Twisk JW; Brouwer CB; Stehouwer CD
J Hum Hypertens; 2006 Aug; 20(8):599-611. PubMed ID: 16673014
[TBL] [Abstract][Full Text] [Related]
26. Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment.
Dahlöf B; Stenkula S; Hansson L
Blood Press; 1992 May; 1(1):35-44. PubMed ID: 1345141
[TBL] [Abstract][Full Text] [Related]
27. Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals.
Beck AL; Otto ME; D'Avila LB; Netto FM; Armendaris MK; Sposito AC
Atherosclerosis; 2012 Jun; 222(2):444-8. PubMed ID: 22554359
[TBL] [Abstract][Full Text] [Related]
28. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
[TBL] [Abstract][Full Text] [Related]
29. Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial.
Skudicky D; Sareli P; Libhaber E; Candy G; Radevski I; Valtchanova Z; Tshele E; Thijs L; Wang JG; Staessen JA
Circulation; 2002 Feb; 105(7):830-6. PubMed ID: 11854123
[TBL] [Abstract][Full Text] [Related]
30. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.
Frishman WH; Goldberger J; Sherman D
J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628
[TBL] [Abstract][Full Text] [Related]
31. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study.
Senior R; Imbs JL; Bory M; Amabile G; Denis B; Zannad F; De Luca N; Marchegiano R; Lahiri A; Raftery EB
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S106-10. PubMed ID: 7508055
[TBL] [Abstract][Full Text] [Related]
32. The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension.
Pan XD; Zeng ZH; Liang LY; Luo JD; Xiao AY; Lai Q; Wen YH; Lu DF; Wang W; He ZC; He WK
Clin Exp Hypertens; 2011; 33(8):558-64. PubMed ID: 21957976
[TBL] [Abstract][Full Text] [Related]
33. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
Sasaki M; Oki T; Iuchi A; Tabata T; Yamada H; Manabe K; Fukuda K; Abe M; Ito S
J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
[TBL] [Abstract][Full Text] [Related]
34. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.
González-Juanatey JR; Reino AP; García-Acuña JM; Varela Román A; Calvo Gómez C; Cabezas-Cerrato J
Am J Cardiol; 1998 Jan; 81(1):87-90. PubMed ID: 9462614
[TBL] [Abstract][Full Text] [Related]
35. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A;
J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969
[TBL] [Abstract][Full Text] [Related]
37. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy.
Roman MJ; Alderman MH; Pickering TG; Pini R; Keating JO; Sealey JE; Devereux RB
Am J Hypertens; 1998 Apr; 11(4 Pt 1):387-96. PubMed ID: 9607375
[TBL] [Abstract][Full Text] [Related]
39. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
[TBL] [Abstract][Full Text] [Related]
40. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).
Devereux RB; Dahlof B; Levy D; Pfeffer MA
Am J Cardiol; 1996 Jul; 78(1):61-5. PubMed ID: 8712120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
